Combined treatment of large hepatocellular carcinoma with transcatheter arterial chemoembolization and percutaneous ethanol injection with a multipronged needle: Experimental and clinical investigation

CardioVascular and Interventional Radiology

Volumn 35, Issue 2, 2012, Pages 325-333

  Kawamura, Rinako ^a   Seki, Toshihito ^a   Umehara, Hideto ^a   Ikeda, Kozo ^a   Inokuchi, Ryosuke ^b   Asayama, Toshiki ^a   Yamaguchi, Takashi ^a   Takahashi, Yu ^a   Sakao, Masayuki ^a   Lencioni, Riccardo ^a   Okazaki, Kazuichi ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

Chemoembolization; Combined therapy; Hepatocellular carcinoma; Multipronged needle; Percutaneous ethanol injection

Indexed keywords

ALCOHOL;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER RECURRENCE; CHEMOEMBOLIZATION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COAGULATION NECROSIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG ADMINISTRATION ROUTE; FEMALE; FOLLOW UP; HUMAN; IN VIVO STUDY; INTERMETHOD COMPARISON; LIVER; LIVER CELL CARCINOMA; MALE; MULTIPRONGED NEEDLE; NECROSIS; NEEDLE; NONHUMAN; PATIENT SAFETY; PERCUTANEOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; SWINE; TREATMENT RESPONSE; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; ANIMALS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; ETHANOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER; LIVER NEOPLASMS; MALE; NEEDLES; NEOPLASM RECURRENCE, LOCAL; SWINE; TREATMENT OUTCOME;

EID: 84862852209     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-011-0184-0     Document Type: Article

References (35)

1. Parkin DM, Bray F, Ferlay J et al. (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108
2. Olsen AH, Parkin DM, Sasieni P (2008) Cancer mortality in the United Kingdom: projections to the year 2025. Br J Cancer 99: 1549-1554
3. Davis GL, Alter MJ, El-Serag H et al. (2010) Aging of the hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology 138: 513-521
4. Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42: 1208-1236
5. Kudo M, Okanoue T, Japan Society of Hepatology (2007) Management of hepatocellular carcinoma in Japan: consensusbased clinical practice manual proposed by the Japan Society of Hepatology. Oncology 72 (Suppl 1): 2-15
6. Lu DS, Yu NC, Raman SS et al. (2005) Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. Radiology 234: 954-960
7. Teratani T, Yoshida H, Shiina S et al. (2006) Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations. Hepatology 43: 1101-1108
8. Crocetti L, De Baere T, Lencioni R (2010) Quality improvement guidelines for radiofrequency ablation of liver tumors. Cardiovasc Intervent Radiol 33: 11-17
9. Sugiura N, Tanaka K, Ohto M et al. (1983) Treatment of small hepatocellular carcinoma by percutaneous injection of ethanol into tumor with real-time ultrasound monitoring. Acta Hepatol Jpn 24: 920
10. Khan KN, Yatsuhashi H, Yamasaki K et al. (2000) Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection. J Hepatol 32: 269-278
11. Koda M, Murawaki Y, Mitsuda A et al. (2000) Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma. Cancer 88: 529-537
12. Kuang M, Lu MD, Xie XY et al. (2009) Ethanol ablation of hepatocellular carcinoma up to 5 cm by using a multipronged injection needle with high-dose strategy. Radiology 253: 552-561
13. Lencioni R, Crocetti L, Cioni D et al. (2010) Single-session percutaneous ethanol ablation of early-stage hepatocellular carcinoma with a multipronged injection needle: results of a pilot clinical study. J Vasc Interv Radiol 21: 1533-1538
14. Tateishi R, Shiina S, Teratani T et al. (2005) Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 103: 1201-1209
15. Lencioni R, Cioni D, Crocetti L et al. (2005) Early-stage hepatocellular carcinoma in cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234: 961-967
16. Choi D, Lim HK, Rhim H et al. (2007) Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol 17: 684-692
17. Livraghi T, Meloni F, Di Stasi M et al. (2008) Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology 47: 82-89
18. N'Kontchou G, Mahamoudi A, Aout M et al. (2009) Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis. Hepatology 50: 1475-1483
19. Inokuchi R, Seki T, Ikeda K et al. (2010) Percutaneous microwave coagulation therapy for hepatocellular carcinoma: increased coagulation diameter using a new electrode and microwave generator. Oncol Rep 24: 621-627
20. Ikeda K, Seki T, Umehara H et al. (2007) Clinicopathologic study of small hepatocellular carcinoma with microscopic satellite nodules to determine the extent of tumor ablation by local therapy. Int J Oncol 31: 485-491
21. Lencioni R, Allgaier HP, Cioni D et al. (2003) Small hepatocellular carcinoma in cirrhosis: randomized comparison of radiofrequency thermal ablation versus percutaneous ethanol injection. Radiology 228: 235-240
22. Lin SM, Lin CJ, Lin CC et al. (2004) Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma\or = 4 cm. Gastroenterology 127: 1714-1723
23. Shiina S, Teratani T, Obi S et al. (2005) A randomized controlled trial of radiofrequency ablation versus ethanol injection for small hepatocellular carcinoma. Gastroenterology 129: 122-130
24. Lin SM, Lin CJ, Lin CC et al. (2005) Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 54: 1151-1156
25. Brunello F, Veltri A, Carucci P et al. (2008) Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: a randomized controlled trial. Scand J Gastroenterol 43: 727-735
26. Orlando A, Leandro G, Olivo M et al. (2009) Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: meta-analysis of randomized controlled trials. Am J Gastroenterol 104: 514-524
27. Cho YK, Kim JK, Kim MY et al. (2009) Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology 49: 453-459
28. Germani G, Pleguezuelo M, Gurusamy K et al. (2010) Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocellular carcinoma: a meta-analysis. J Hepatol 52: 380-388
29. Komorizono Y, Oketani M, Sako K et al. (2003) Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer 97: 1253-1262
30. Kim SW, Rhim H, Park M et al. (2009) Percutaneous radiofrequency ablation of hepatocellular carcinomas adjacent to the gallbladder with internally cooled electrodes: assessment of safety and therapeutic efficacy. Korean J Radiol 10: 366-376
31. Chen MH, Wei Y, Yan K et al. (2006) Treatment strategy to optimize radiofrequency ablation for liver malignancies. J Vasc Interv Radiol 17: 671-683
32. Ebara M, Okabe S, Kita K et al. (2005) Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation. J Hepatol 43: 458-464
33. Tanaka K, Nakamura S, Numata K et al. (1992) Hepatocellular carcinoma: treatment with percutaneous ethanol injection and transcatheter arterial embolization. Radiology 85: 457-460
34. Lencioni R, Paolicchi A, Moretti M et al. (1998) Combined transcatheter arterial chemoembolization and percutaneous ethanol injection for the treatment of large hepatocellular carcinoma: local therapeutic effect and long-term survival rate. Eur Radiol 8: 439-444
35. Herber S, Biesterfeld S, Franz U et al. (2008) Correlation of multislice CT and histomorphology in HCC following TACE: predictors of outcome. Cardiovasc Intervent Radiol 31: 768-777